Topadur Pharma
Schlieren, Switzerland· Est. 2012
by enhancing life quality through first-in-class therapies that restore local blood circulation
Private Company
Total funding raised: $12.5M
About
by enhancing life quality through first-in-class therapies that restore local blood circulation
Small Molecules
Funding History
2Total raised:$12.5M
Series A$10MJun 15, 2020
Seed$2.5MJun 15, 2017